Ecstasy may become an FDA-approved medical treatment in five years
Shared from Google News & Weather
As long as it’s used for medical purposes and obtained lawfully, marijuana can be legally purchased in the United States by those with access to medical marijuana doctors and cards as long as they meet eligibility criteria. Furthermore, many states are already legalizing the drug for recreational use leading to large numbers of people wanting to know how to use a weed grinder when they’re preparing to smoke.
The legalization of marijuana is also leading to an increase in the number of cannabis businesses, such as https://bakedlink.com/, as the respectability of the substance increases. Legitimacy in the sector has led to an explosion of other service providers as more people become interested in trying the substance. In order to keep up with demand however, cannabis businesses are having to invest in new growing methods and technology to stay ahead of the competition. For example, there is now a variety of seed to sale software options out there that cannabis-related businesses can use to enhance their crops.
However, could other drugs be legalized soon too?
MDMA (a.k.a. ecstasy) is a party drug that’s showing great promise in treating PTSD and other anxiety-related disorders.
The Multidisciplinary Association for Psychedelic Studies (MAPS) expects the FDA to approve MDMA as soon as 2021 if the clinical trials perform according to plan. The medical version is the pure form of the illegal party drug, and it’s less dangerous than what’s illegally sold on the street, Business Insider reports.
MAPS performed a study on 20 PTSD patients and found that 83% of the study participants no longer showed signs two months after the treatment. Follow ups conducted an average of four years later showed that the benefits stuck. All 20 patients had psychotherapy as well, but just 12 of them were given ecstasy. The others were on placebo and 25% of them showed improvement.